Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial

Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial

Abstract Background Uncontrolled active rheumatoid arthritis can lead to increasing disability and reduced quality of life over time. ‘Treating to target’ has been shown to be effective in active established disease and also in early disease. However, there is a lack of nationally agreed treatment p...

Full description

Bibliographic Details
Main Authors: Naomi H. Martin, Fowzia Ibrahim, Brian Tom, James Galloway, Allan Wailoo, Jonathan Tosh, Heidi Lempp, Louise Prothero, Sofia Georgopoulou, Jackie Sturt, David L. Scott, On behalf of TITRATE Programme Investigators
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Trials
Subjects:
Rheumatoid arthritis
Intermediate disease activity
Treating to target
Intensive treatment
Randomised controlled trial
Tumour necrosis factor inhibitors
Online Access:http://link.springer.com/article/10.1186/s13063-017-2330-8

Internet

http://link.springer.com/article/10.1186/s13063-017-2330-8

Similar Items